Phase
Condition
Diabetes Mellitus, Type 2
Diabetic Neuropathy
Diabetic Retinopathy
Treatment
Continuous Glucose Monitoring (CGM)
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-75 years
Type 2 diabetes mellitus
HbA1C ≥ 7.5%
At least on 1 insulin injection therapy daily
Patients established with primary care clinic or endocrinology clinic or diabetesclinics in the New Orleans and surrounding areas
Patients with Medicaid or free care or uninsured
Patients must be able to speak and understand English and be capable of providinginformed consent to participate in the study
Exclusion
Exclusion Criteria:
Type 1 diabetes mellitus
Currently on CGM or using insulin pump
Advanced renal disease or Estimated Glomerular Filtration Rate (eGFR) <40
Serious co-morbidities which in the investigator's opinion, will make it challengingfor patients to participate
The patient has been diagnosed with end-stage renal disease, is on dialysis, or hashad a kidney transplant, Hemoglobinopathies, iron therapy or other condition thatinterferes with HbA1c measurement
Pregnant
Study Design
Study Description
Connect with a study center
University Medical Center
New Orleans, Louisiana 70112
United StatesActive - Recruiting
University Medical Center
New Orleans 4335045, Louisiana 4331987 70112
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.